Journal ArticleOPEN ACCESS

COVID-19 VACCINES AND ATRIAL FIBRILLATION RISK: A PHARMACOVIGILANCE ANALYSIS

  • Kattubadi A
  • Solorzano J
  • Feng K
  • et al.
Journal of the American College of Cardiology (2022) 79(9) 1838
DOI: 10.1016/s0735-1097(22)02829-7
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The COVID-19 vaccines were developed in record times and have proven to be safe and efficacious in reducing transmissibility and severe infection. As these vaccines are new, there is a need for understanding potential adverse effects (AE) and to take appropriate measures to reduce untoward disease burden.

Cite

CITATION STYLE

APA

Kattubadi, A., Solorzano, J., Feng, K., Brar, V., & Dominic, P. (2022). COVID-19 VACCINES AND ATRIAL FIBRILLATION RISK: A PHARMACOVIGILANCE ANALYSIS. Journal of the American College of Cardiology, 79(9), 1838. https://doi.org/10.1016/s0735-1097(22)02829-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free